{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:55:06Z","timestamp":1793260506328,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03900-2","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:34:22Z","timestamp":1770694462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical and biological markers of electroconvulsive therapy effectiveness: a narrative review"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-9732","authenticated-orcid":false,"given":"David","family":"Zilles-Wegner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-9495","authenticated-orcid":false,"given":"Iven-Alex","family":"von M\u00fccke-Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2650-6080","authenticated-orcid":false,"given":"Antoine","family":"Yrondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-6673","authenticated-orcid":false,"given":"Akihiro","family":"Takamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"3900_CR1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza RT, Kellner CH. Electroconvulsive therapy. N Engl J Med. 2022;386:667\u201372.","journal-title":"N Engl J Med"},{"key":"3900_CR2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/02537176251317677","volume":"47","author":"J Thirthalli","year":"2025","unstructured":"Thirthalli J. Underutilization of electroconvulsive therapy (ECT): a call for urgent attention. Indian J Psychol Med. 2025;47:103\u20137.","journal-title":"Indian J Psychol Med"},{"key":"3900_CR3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","volume":"59","author":"HC Kraemer","year":"2002","unstructured":"Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877\u201383.","journal-title":"Arch Gen Psychiatry"},{"key":"3900_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.31887\/DCNS.2008.10.4\/gipapakostas","volume":"10","author":"GI Papakostas","year":"2008","unstructured":"Papakostas GI, Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci. 2008;10:439\u201351.","journal-title":"Dialogues Clin Neurosci"},{"key":"3900_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/1097-4679(195007)6:3<285::AID-JCLP2270060316>3.0.CO;2-T","volume":"6","author":"JS Pearson","year":"1950","unstructured":"Pearson JS. Prediction of the response of schizophrenic patients to electroconvulsive therapy. J Clin Psychol. 1950;6:285\u20137.","journal-title":"J Clin Psychol"},{"key":"3900_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.109.459.213","volume":"109","author":"JT Rose","year":"1963","unstructured":"Rose JT. Reactive and endogenous depressions-response to E.C.T. Br J Psychiatry. 1963;109:213\u20137.","journal-title":"Br J Psychiatry"},{"key":"3900_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/ajp.124.2.153","volume":"124","author":"J Mendels","year":"1967","unstructured":"Mendels J. The prediction of response to electroconvulsive therapy. Am J Psychiatry. 1967;124:153\u20139.","journal-title":"Am J Psychiatry"},{"key":"3900_CR8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","volume":"30","author":"WT Heijnen","year":"2010","unstructured":"Heijnen WT, Birkenh\u00e4ger TK, Wierdsma AI, van den Broek WW. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30:616\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"3900_CR9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","volume":"76","author":"AU Haq","year":"2015","unstructured":"Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374\u201384.","journal-title":"J Clin Psychiatry"},{"key":"3900_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","volume":"212","author":"L van Diermen","year":"2018","unstructured":"van Diermen L, van den Ameele S, Kamperman AM, Sabbe BCG, Vermeulen T, Schrijvers D, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018;212:71\u201380.","journal-title":"Br J Psychiatry"},{"key":"3900_CR11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","volume":"388","author":"A Anand","year":"2023","unstructured":"Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, et al. Ketamine versus ECT for nonpsychotic treatment-resistant major depression. N Engl J Med. 2023;388:2315\u201325.","journal-title":"N Engl J Med"},{"key":"3900_CR12","doi-asserted-by":"crossref","first-page":"e2417786","DOI":"10.1001\/jamanetworkopen.2024.17786","volume":"7","author":"MK Jha","year":"2024","unstructured":"Jha MK, Wilkinson ST, Krishnan K, Collins KA, Sanacora G, Murrough J, et al. Ketamine vs electroconvulsive therapy for treatment-resistant depression: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7:e2417786.","journal-title":"JAMA Netw Open"},{"key":"3900_CR13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/YCT.0000000000001034","volume":"40","author":"D Zilles-Wegner","year":"2024","unstructured":"Zilles-Wegner D, Kellner CH, Sartorius A. Electroconvulsive therapy and its new competitors: ECT remains the gold standard. J ECT. 2024;40:e31\u2013e32.","journal-title":"J ECT"},{"key":"3900_CR14","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyad065","volume":"27","author":"J Ekstrand","year":"2024","unstructured":"Ekstrand J, Takamiya A, Nordenskjold A, Kirov G, Sienaert P, Kellner CH, et al. Ketamine or ECT? what have we learned from the KetECT and ELEKT-D trials?. Int J Neuropsychopharmacol. 2024;27:pyad065.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3900_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ijnp\/pyab088","volume":"25","author":"J Ekstrand","year":"2022","unstructured":"Ekstrand J, Fattah C, Persson M, Cheng T, Nordanskog P, \u00c5keson J, et al. Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT). Int J Neuropsychopharmacol. 2022;25:339\u201349.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3900_CR16","doi-asserted-by":"crossref","first-page":"20m13287","DOI":"10.4088\/JCP.20m13287","volume":"82","author":"L van Diermen","year":"2020","unstructured":"van Diermen L, Poljac E, Van der Mast R, Plasmans K, Van den Ameele S, Heijnen W, et al. Toward targeted ECT: the interdependence of predictors of treatment response in depression further explained. J Clin Psychiatry. 2020;82:20m13287.","journal-title":"J Clin Psychiatry"},{"key":"3900_CR17","volume":"55","author":"A Jelovac","year":"2025","unstructured":"Jelovac A, Landau S, Beeley P, McCaffrey C, Finnegan M, Gusciute G, et al. Why is electroconvulsive therapy for depression more effective in older age? A causal mediation analysis. Psychol Med. 2025;55:e110.","journal-title":"Psychol Med"},{"key":"3900_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpsychires.2018.11.014","volume":"109","author":"WTCJ Heijnen","year":"2019","unstructured":"Heijnen WTCJ, Kamperman AM, Tjokrodipo LD, Hoogendijk WJG, van den Broek WW, Birkenhager TK. Influence of age on ECT efficacy in depression and the mediating role of psychomotor retardation and psychotic features. J Psychiatr Res. 2019;109:41\u201347.","journal-title":"J Psychiatr Res"},{"key":"3900_CR19","doi-asserted-by":"crossref","first-page":"24m15399","DOI":"10.4088\/JCP.24m15399","volume":"86","author":"R Kelkar","year":"2025","unstructured":"Kelkar R, Liu GC, Goodman MS, Al-Hashemi A, Rhee TG, Blumberger DM, et al. Clinical effectiveness of electroconvulsive therapy for psychotic vs nonpsychotic depression: a cohort study. J Clin Psychiatry. 2025;86:24m15399.","journal-title":"J Clin Psychiatry"},{"key":"3900_CR20","doi-asserted-by":"crossref","first-page":"21m14287","DOI":"10.4088\/JCP.21m14287","volume":"83","author":"MJ Wagenmakers","year":"2022","unstructured":"Wagenmakers MJ, Oudega ML, Bouckaert F, Rhebergen D, Beekman ATF, Veltman DJ, et al. Remission rates following electroconvulsive therapy and relation to index episode duration in patients with psychotic versus nonpsychotic late-life depression. J Clin Psychiatry. 2022;83:21m14287.","journal-title":"J Clin Psychiatry"},{"key":"3900_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/acps.13425","volume":"146","author":"P Sienaert","year":"2022","unstructured":"Sienaert P, Brus O, Lambrichts S, Lundberg J, Nordanskog P, Obbels J, et al. Suicidal ideation and ECT, ECT and suicidal ideation: A register study. Acta Psychiatr Scand. 2022;146:74\u201384.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1192\/bjp.2024.126","volume":"225","author":"DM Semple","year":"2024","unstructured":"Semple DM, Suveges S, Steele JD. Electroconvulsive therapy response and remission in moderate to severe depressive illness: a decade of national Scottish data. Br J Psychiatry. 2024;225:547\u201355.","journal-title":"Br J Psychiatry"},{"key":"3900_CR23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.brs.2022.09.001","volume":"15","author":"A Takamiya","year":"2022","unstructured":"Takamiya A, Sienaert P, Gergel T, Gather J, Kishimoto T, Zilles-Wegner D. Effectiveness of electroconvulsive therapy in patients lacking decision making capacity: A systematic review and meta-analysis. Brain Stimul. 2022;15:1246\u201353.","journal-title":"Brain Stimul"},{"key":"3900_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/acps.13770","volume":"151","author":"TF Blanken","year":"2025","unstructured":"Blanken TF, Kok R, Obbels J, Lambrichts S, Sienaert P, Verwijk E. Prediction of electroconvulsive therapy outcome: A network analysis approach. Acta Psychiatr Scand. 2025;151:521\u20138.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR25","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115328","volume":"326","author":"Y van der Does","year":"2023","unstructured":"van der Does Y, Turner RJ, Bartels MJH, Hagoort K, Metselaar A, Scheepers F, et al. Outcome prediction of electroconvulsive therapy for depression. Psychiatry Res. 2023;326:115328.","journal-title":"Psychiatry Res"},{"key":"3900_CR26","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41380-024-02803-2","volume":"30","author":"D Loef","year":"2025","unstructured":"Loef D, Hoogendoorn AW, Somers M, Mocking RJT, Scheepens DS, Scheepstra KWF, et al. A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC). Mol Psychiatry. 2025;30:1915\u201324.","journal-title":"Mol Psychiatry"},{"key":"3900_CR27","doi-asserted-by":"crossref","first-page":"21m14293","DOI":"10.4088\/JCP.21m14293","volume":"83","author":"K Nakajima","year":"2022","unstructured":"Nakajima K, Takamiya A, Uchida T, Kudo S, Nishida H, Minami F, et al. Individual prediction of remission based on clinical features following electroconvulsive therapy: a machine learning approach. J Clin Psychiatry. 2022;83:21m14293.","journal-title":"J Clin Psychiatry"},{"key":"3900_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02582-4","volume":"13","author":"L Kaurani","year":"2023","unstructured":"Kaurani L, Besse M, Methfessel I, Methi A, Zhou J, Pradhan R, et al. Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression. Transl Psychiatry. 2023;13:294.","journal-title":"Transl Psychiatry"},{"key":"3900_CR29","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1038\/s41380-024-02874-1","volume":"30","author":"Y Ishikawa","year":"2025","unstructured":"Ishikawa Y, Oishi N, Kyuragi Y, Hatakoshi M, Hirano J, Noda T, et al. Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depression. Mol Psychiatry. 2025;30:2653\u201364.","journal-title":"Mol Psychiatry"},{"key":"3900_CR30","doi-asserted-by":"crossref","first-page":"110146","DOI":"10.1016\/j.pnpbp.2020.110146","volume":"105","author":"J-B Belge","year":"2021","unstructured":"Belge J-B, Van Diermen L, Sabbe B, Moens J, Morrens M, Coppens V, et al. Improvement of psychomotor retardation after electroconvulsive therapy is related to decreased IL-6 levels. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105:110146.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3900_CR31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.21034","volume":"22","author":"OA Andreassen","year":"2023","unstructured":"Andreassen OA, Hindley GFL, Frei O, Smeland OB. New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. World Psychiatry. 2023;22:4\u201324.","journal-title":"World Psychiatry"},{"key":"3900_CR32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","volume":"8","author":"N Tsankova","year":"2007","unstructured":"Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci. 2007;8:355\u201367.","journal-title":"Nat Rev Neurosci"},{"key":"3900_CR33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn3879","volume":"16","author":"O Issler","year":"2015","unstructured":"Issler O, Chen A. Determining the role of microRNAs in psychiatric disorders. Nat Rev Neurosci. 2015;16:201\u201312.","journal-title":"Nat Rev Neurosci"},{"key":"3900_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01474-9","volume":"11","author":"L Sirignano","year":"2021","unstructured":"Sirignano L, Frank J, Kranaster L, Witt SH, Streit F, Zillich L, et al. Methylome-wide change associated with response to electroconvulsive therapy in depressed patients. Transl Psychiatry. 2021;11:347.","journal-title":"Transl Psychiatry"},{"key":"3900_CR35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.2011.11020191","volume":"168","author":"LE Duncan","year":"2011","unstructured":"Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry. 2011;168:1041\u20139.","journal-title":"Am J Psychiatry"},{"key":"3900_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.ajp.2018.18070881","volume":"176","author":"R Border","year":"2019","unstructured":"Border R, Johnson EC, Evans LM, Smolen A, Berley N, Sullivan PF, et al. No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am J Psychiatry. 2019;176:376\u201387.","journal-title":"Am J Psychiatry"},{"key":"3900_CR37","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.brs.2018.05.011","volume":"11","author":"KM Ryan","year":"2018","unstructured":"Ryan KM, Dunne R, McLoughlin DM. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy. Brain Stimul. 2018;11:1123\u201331.","journal-title":"Brain Stimul"},{"key":"3900_CR38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/YCT.0000000000000170","volume":"31","author":"CA Bousman","year":"2015","unstructured":"Bousman CA, Katalinic N, Martin DM, Smith DJ, Ingram A, Dowling N, et al. Effects of COMT, DRD2, BDNF, and APOE genotypic variation on treatment efficacy and cognitive side effects of electroconvulsive therapy. J ECT. 2015;31:129\u201335.","journal-title":"J ECT"},{"key":"3900_CR39","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.psyneuen.2009.05.021","volume":"34","author":"EB Binder","year":"2009","unstructured":"Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009;34:S186\u2013195.","journal-title":"Psychoneuroendocrinology"},{"key":"3900_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2021.06.039","volume":"141","author":"I Israel-Elgali","year":"2021","unstructured":"Israel-Elgali I, Hertzberg L, Shapira G, Segev A, Krieger I, Nitzan U, et al. Blood transcriptional response to treatment-resistant depression during electroconvulsive therapy. J Psychiatr Res. 2021;141:92\u2013103.","journal-title":"J Psychiatr Res"},{"key":"3900_CR41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ajmg.b.30949","volume":"153B","author":"K Domschke","year":"2010","unstructured":"Domschke K, Zavorotnyy M, Diemer J, Nitsche S, Hohoff C, Baune BT, et al. COMT val158met influence on electroconvulsive therapy response in major depression. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:286\u201390.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3900_CR42","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s12013-014-0361-2","volume":"71","author":"Z Lin","year":"2015","unstructured":"Lin Z, He H, Zhang C, Wang Z, Jiang M, Li Q, et al. Influence of Val108\/158Met COMT gene polymorphism on the efficacy of modified electroconvulsive therapy in patients with treatment resistant depression. Cell Biochem Biophys. 2015;71:1387\u201393.","journal-title":"Cell Biochem Biophys"},{"key":"3900_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2008.10.015","volume":"448","author":"K Huuhka","year":"2008","unstructured":"Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, et al. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neurosci Lett. 2008;448:79\u201383.","journal-title":"Neurosci Lett"},{"key":"3900_CR44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.02.023","volume":"493","author":"M Viikki","year":"2011","unstructured":"Viikki M, Kampman O, Anttila S, Illi A, Set\u00e4l\u00e4-Soikkeli E, Huuhka M, et al. P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neurosci Lett. 2011;493:127\u201330.","journal-title":"Neurosci Lett"},{"key":"3900_CR45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2015.01.077","volume":"590","author":"M Kautto","year":"2015","unstructured":"Kautto M, Kampman O, Mononen N, Lehtim\u00e4ki T, Haraldsson S, Koivisto PA, et al. Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression. Neurosci Lett. 2015;590:116\u201320.","journal-title":"Neurosci Lett"},{"key":"3900_CR46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/09540261.2022.2101352","volume":"34","author":"L Fusar-Poli","year":"2022","unstructured":"Fusar-Poli L, Rutten BPF, van Os J, Aguglia E, Guloksuz S. Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?. Int Rev Psychiatry. 2022;34:663\u201375.","journal-title":"Int Rev Psychiatry"},{"key":"3900_CR47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1176\/appi.ajp.20220783","volume":"179","author":"BPF Rutten","year":"2022","unstructured":"Rutten BPF, van Bronswijk SC. Proof-of-principle study on ECT illustrates challenges and possible merits of using polygenic risk scores to predict treatment response in psychiatry. Am J Psychiatry. 2022;179:794\u20137.","journal-title":"Am J Psychiatry"},{"key":"3900_CR48","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/s41380-020-00984-0","volume":"26","author":"CC Clements","year":"2021","unstructured":"Clements CC, Karlsson R, Lu Y, Jur\u00e9us A, R\u00fcck C, Andersson E, et al. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy. Mol Psychiatry. 2021;26:2429\u201339.","journal-title":"Mol Psychiatry"},{"key":"3900_CR49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343\u201352.","journal-title":"Nat Neurosci"},{"key":"3900_CR50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ajmg.b.32700","volume":"180","author":"JC Foo","year":"2019","unstructured":"Foo JC, Streit F, Frank J, Witt SH, Treutlein J, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, et al. Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy. Am J Med Genet B Neuropsychiatr Genet. 2019;180:35\u201345.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3900_CR51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.22010045","volume":"179","author":"R Sigstr\u00f6m","year":"2022","unstructured":"Sigstr\u00f6m R, Kowalec K, Jonsson L, Clements CC, Karlsson R, Nordenskj\u00f6ld A, et al. Association between polygenic risk scores and outcome of ECT. Am J Psychiatry. 2022;179:844\u201352.","journal-title":"Am J Psychiatry"},{"key":"3900_CR52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopsych.2021.10.013","volume":"91","author":"JJ Luykx","year":"2022","unstructured":"Luykx JJ, Loef D, Lin B, van Diermen L, Nuninga JO, van Exel E, et al. Interrogating associations between polygenic liabilities and electroconvulsive therapy effectiveness. Biol Psychiatry. 2022;91:531\u20139.","journal-title":"Biol Psychiatry"},{"key":"3900_CR53","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00406-019-01087-w","volume":"270","author":"T Soda","year":"2020","unstructured":"Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, et al. International consortium on the genetics of electroconvulsive therapy and severe depressive disorders (Gen-ECT-ic). Eur Arch Psychiatry Clin Neurosci. 2020;270:921\u201332.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3900_CR54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamapsychiatry.2018.1725","volume":"75","author":"O Story Jovanova","year":"2018","unstructured":"Story Jovanova O, Nedeljkovic I, Spieler D, Walker RM, Liu C, Luciano M, et al. DNA methylation signatures of depressive symptoms in middle-aged and elderly persons: meta-analysis of multiethnic epigenome-wide studies. JAMA Psychiatry. 2018;75:949\u201359.","journal-title":"JAMA Psychiatry"},{"key":"3900_CR55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41380-024-02749-5","volume":"30","author":"DJ Kiltschewskij","year":"2025","unstructured":"Kiltschewskij DJ, Reay WR, Cairns MJ. Schizophrenia is associated with altered DNA methylation variance. Mol Psychiatry. 2025;30:1383\u201395.","journal-title":"Mol Psychiatry"},{"key":"3900_CR56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biopsych.2014.12.009","volume":"78","author":"M Geaghan","year":"2015","unstructured":"Geaghan M, Cairns MJ. MicroRNA and posttranscriptional dysregulation in psychiatry. Biol Psychiatry. 2015;78:231\u20139.","journal-title":"Biol Psychiatry"},{"key":"3900_CR57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nm.3582","volume":"20","author":"JP Lopez","year":"2014","unstructured":"Lopez JP, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B, et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med. 2014;20:764\u20138.","journal-title":"Nat Med"},{"key":"3900_CR58","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1073\/pnas.1113793109","volume":"109","author":"BH Miller","year":"2012","unstructured":"Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J, et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci USA. 2012;109:3125\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3900_CR59","volume":"17","author":"SCC Castro","year":"2023","unstructured":"Castro SCC, Bicca C, Bicca B, Araujo S, Viola TW. A systematic mini-review of epigenetic mechanisms associated with electroconvulsive therapy in humans. Front Hum Neurosci. 2023;17:1143332.","journal-title":"Front Hum Neurosci"},{"key":"3900_CR60","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-014-1336-6","volume":"122","author":"A Kleimann","year":"2015","unstructured":"Kleimann A, Kotsiari A, Sperling W, Gr\u00f6schl M, Heberlein A, Kahl KG, et al. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy. J Neural Transm (Vienna). 2015;122:925\u20138.","journal-title":"J Neural Transm (Vienna)"},{"key":"3900_CR61","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-017-0077-3","volume":"8","author":"A Neyazi","year":"2018","unstructured":"Neyazi A, Theilmann W, Brandt C, Rantam\u00e4ki T, Matsui N, Rhein M, et al. P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy. Transl Psychiatry. 2018;8:25.","journal-title":"Transl Psychiatry"},{"key":"3900_CR62","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-020-00891-9","volume":"12","author":"N Moschny","year":"2020","unstructured":"Moschny N, Zindler T, Jahn K, Dorda M, Davenport CF, Wiehlmann L, et al. Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy. Clin Epigenetics. 2020;12:114.","journal-title":"Clin Epigenetics"},{"key":"3900_CR63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euroneuro.2022.07.183","volume":"63","author":"G Schurgers","year":"2022","unstructured":"Schurgers G, Walter S, Pishva E, Guloksuz S, Peerbooms O, Incio LR, et al. Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy. Eur Neuropsychopharmacol. 2022;63:60\u201370.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3900_CR64","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fpsyt.2020.00571","volume":"11","author":"N Moschny","year":"2020","unstructured":"Moschny N, Jahn K, Bajbouj M, Maier HB, Ballmaier M, Khan AQ, et al. DNA methylation of the t-PA gene differs between various immune cell subtypes isolated from depressed patients receiving electroconvulsive therapy. Front Psychiatry. 2020;11:571.","journal-title":"Front Psychiatry"},{"key":"3900_CR65","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-024-01704-z","volume":"16","author":"R Carvalho Silva","year":"2024","unstructured":"Carvalho Silva R, Martini P, Hohoff C, Mattevi S, Bortolomasi M, Abate M, et al. Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study. Clin Epigenetics. 2024;16:93.","journal-title":"Clin Epigenetics"},{"key":"3900_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.131","volume":"6","author":"A Gururajan","year":"2016","unstructured":"Gururajan A, Naughton ME, Scott KA, O\u2019Connor RM, Moloney G, Clarke G, et al. MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c. Transl Psychiatry. 2016;6:e862.","journal-title":"Transl Psychiatry"},{"key":"3900_CR67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/acps.12821","volume":"136","author":"E Kolshus","year":"2017","unstructured":"Kolshus E, Ryan KM, Blackshields G, Smyth P, Sheils O, McLoughlin DM. Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. Acta Psychiatr Scand. 2017;136:594\u2013606.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR68","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/YCT.0000000000001100","volume":"41","author":"C Galbiati","year":"2025","unstructured":"Galbiati C, Dattilo V, Bortolomasi M, Vitali E, Abate M, Menesello V, et al. Plasma microRNA levels after electroconvulsive therapy in treatment-resistant depressed patients. J ECT. 2025;41:232\u20137. https:\/\/doi.org\/10.1097\/YCT.0000000000001100.","journal-title":"J ECT"},{"key":"3900_CR69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"3900_CR70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","volume":"23","author":"AH Miller","year":"2009","unstructured":"Miller AH. Norman cousins lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun. 2009;23:149\u201358.","journal-title":"Brain Behav Immun"},{"key":"3900_CR71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732\u201341.","journal-title":"Biol Psychiatry"},{"key":"3900_CR72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0304-3940(88)90585-X","volume":"85","author":"MB Graeber","year":"1988","unstructured":"Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW. Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett. 1988;85:317\u201321.","journal-title":"Neurosci Lett"},{"key":"3900_CR73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01674208","volume":"17","author":"MB Graeber","year":"1988","unstructured":"Graeber MB, Kreutzberg GW. Delayed astrocyte reaction following facial nerve axotomy. J Neurocytol. 1988;17:209\u201320.","journal-title":"J Neurocytol"},{"key":"3900_CR74","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1750-3639.1990.tb00630.x","volume":"1","author":"MB Graeber","year":"1990","unstructured":"Graeber MB, Streit WJ. Microglia: immune network in the CNS. Brain Pathol. 1990;1:2\u20135.","journal-title":"Brain Pathol"},{"key":"3900_CR75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312\u20138.","journal-title":"Trends Neurosci"},{"key":"3900_CR76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/B:MEBR.0000043984.73063.d8","volume":"19","author":"D van Rossum","year":"2004","unstructured":"van Rossum D, Hanisch U-K. Microglia. Metab Brain Dis. 2004;19:393\u2013411.","journal-title":"Metab Brain Dis"},{"key":"3900_CR77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","volume":"40","author":"U-K Hanisch","year":"2002","unstructured":"Hanisch U-K. Microglia as a source and target of cytokines. Glia. 2002;40:140\u201355.","journal-title":"Glia"},{"key":"3900_CR78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/glia.440010502","volume":"1","author":"WJ Streit","year":"1988","unstructured":"Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. Glia. 1988;1:301\u20137.","journal-title":"Glia"},{"key":"3900_CR79","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/pharmrev.120.000043","volume":"73","author":"MJ Lucido","year":"2021","unstructured":"Lucido MJ, Bekhbat M, Goldsmith DR, Treadway MT, Haroon E, Felger JC, et al. Aiding and abetting anhedonia: impact of inflammation on the brain and pharmacological implications. Pharmacol Rev. 2021;73:1084\u2013117.","journal-title":"Pharmacol Rev"},{"key":"3900_CR80","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamapsychiatry.2025.0206","volume":"82","author":"MK Jha","year":"2025","unstructured":"Jha MK, Leboyer M, Pariante CM, Miller AH. Should inflammation be a specifier for major depression in the DSM-6?. JAMA Psychiatry. 2025;82:549\u201350.","journal-title":"JAMA Psychiatry"},{"key":"3900_CR81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106060","volume":"170","author":"A Dellink","year":"2025","unstructured":"Dellink A, Vanderhaegen G, Coppens V, Ryan KM, McLoughlin DM, Kruse J, et al. Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysis. Neurosci Biobehav Rev. 2025;170:106060.","journal-title":"Neurosci Biobehav Rev"},{"key":"3900_CR82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2020.05.069","volume":"89","author":"JL Kruse","year":"2020","unstructured":"Kruse JL, Olmstead R, Hellemann G, Wade B, Jiang J, Vasavada MM, et al. Inflammation and depression treatment response to electroconvulsive therapy: sex-specific role of interleukin-8. Brain Behav Immun. 2020;89:59\u201366.","journal-title":"Brain Behav Immun"},{"key":"3900_CR83","volume":"8","author":"A Sorri","year":"2018","unstructured":"Sorri A, J\u00e4rventausta K, Kampman O, Lehtim\u00e4ki K, Bj\u00f6rkqvist M, Tuohimaa K, et al. Low tumor necrosis factor-\u03b1 levels predict symptom reduction during electroconvulsive therapy in major depressive disorder. Brain Behav. 2018;8:e00933.","journal-title":"Brain Behav"},{"key":"3900_CR84","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jad.2019.06.040","volume":"256","author":"A Carlier","year":"2019","unstructured":"Carlier A, Berkhof JG, Rozing M, Bouckaert F, Sienaert P, Eikelenboom P, et al. Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study\u2730. J Affect Disord. 2019;256:509\u201316.","journal-title":"J Affect Disord"},{"key":"3900_CR85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000506133","volume":"79","author":"J-B Belge","year":"2020","unstructured":"Belge J-B, van Diermen L, Sabbe B, Parizel P, Morrens M, Coppens V, et al. Inflammation, hippocampal volume, and therapeutic outcome following electroconvulsive therapy in depressive patients: a pilot study. Neuropsychobiology. 2020;79:222\u201332.","journal-title":"Neuropsychobiology"},{"key":"3900_CR86","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/NDT.S106652","volume":"12","author":"S Zincir","year":"2016","unstructured":"Zincir S, \u00d6zt\u00fcrk P, Bilgen AE, \u0130zci F, Y\u00fckselir C. Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression. Neuropsychiatr Dis Treat. 2016;12:1389\u201396.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3900_CR87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","volume":"100","author":"AP Allen","year":"2018","unstructured":"Allen AP, Naughton M, Dowling J, Walsh A, O\u2019Shea R, Shorten G, et al. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy. J Psychiatr Res. 2018;100:24\u201332.","journal-title":"J Psychiatr Res"},{"key":"3900_CR88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","volume":"11","author":"A Yrondi","year":"2018","unstructured":"Yrondi A, Sporer M, P\u00e9ran P, Schmitt L, Arbus C, Sauvaget A. Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review. Brain Stimul. 2018;11:29\u201351.","journal-title":"Brain Stimul"},{"key":"3900_CR89","volume":"297","author":"F Gay","year":"2021","unstructured":"Gay F, Romeo B, Martelli C, Benyamina A, Hamdani N. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis. Psychiatry Res. 2021;297:113735.","journal-title":"Psychiatry Res"},{"key":"3900_CR90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2016.06.035","volume":"205","author":"G Rush","year":"2016","unstructured":"Rush G, O\u2019Donovan A, Nagle L, Conway C, McCrohan A, O\u2019Farrelly C, et al. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy. J Affect Disord. 2016;205:60\u201368.","journal-title":"J Affect Disord"},{"key":"3900_CR91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00124509-200312000-00002","volume":"19","author":"KA Hestad","year":"2003","unstructured":"Hestad KA, T\u00f8nseth S, St\u00f8en CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183\u20138.","journal-title":"J ECT"},{"key":"3900_CR92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YCT.0b013e3181571abb","volume":"24","author":"K Lehtim\u00e4ki","year":"2008","unstructured":"Lehtim\u00e4ki K, Ker\u00e4nen T, Huuhka M, Palmio J, Hurme M, Leinonen E, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 2008;24:88\u201391.","journal-title":"J ECT"},{"key":"3900_CR93","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.euroneuro.2012.10.012","volume":"23","author":"V Stelzhammer","year":"2013","unstructured":"Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, et al. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharmacol. 2013;23:1199\u2013207.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3900_CR94","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jad.2010.11.035","volume":"131","author":"SBAHA Fluitman","year":"2011","unstructured":"Fluitman SBAHA, Heijnen CJ, Denys DAJP, Nolen WA, Balk FJ, Westenberg HGM. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord. 2011;131:388\u201392.","journal-title":"J Affect Disord"},{"key":"3900_CR95","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(01)00399-8","volume":"71","author":"Z Kronfol","year":"2002","unstructured":"Kronfol Z, Nair MP, Weinberg V, Young EA, Aziz M. Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord. 2002;71:211\u20135.","journal-title":"J Affect Disord"},{"key":"3900_CR96","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.100","volume":"5","author":"EM van Buel","year":"2015","unstructured":"van Buel EM, Patas K, Peters M, Bosker FJ, Eisel ULM, Klein HC. Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?. Transl Psychiatry. 2015;5:e609.","journal-title":"Transl Psychiatry"},{"key":"3900_CR97","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopsych.2021.05.023","volume":"91","author":"OT Ousdal","year":"2022","unstructured":"Ousdal OT, Brancati GE, Kessler U, Erchinger V, Dale AM, Abbott C, et al. The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go?. Biol Psychiatry. 2022;91:540\u20139.","journal-title":"Biol Psychiatry"},{"key":"3900_CR98","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/15622975.2021.1907718","volume":"22","author":"A Carlier","year":"2021","unstructured":"Carlier A, Rhebergen D, Schilder F, Bouckaert F, Sienaert P, Veerhuis R, et al. The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients. World J Biol Psychiatry. 2021;22:770\u20137.","journal-title":"World J Biol Psychiatry"},{"key":"3900_CR99","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2000.740457.x","volume":"74","author":"L Vitkovic","year":"2000","unstructured":"Vitkovic L, Bockaert J, Jacque C. Inflammatory\u2019 cytokines: neuromodulators in normal brain?. J Neurochem. 2000;74:457\u201371.","journal-title":"J Neurochem"},{"key":"3900_CR100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fncel.2017.00270","volume":"11","author":"G Singhal","year":"2017","unstructured":"Singhal G, Baune BT. Microglia: an interface between the loss of neuroplasticity and depression. Front Cell Neurosci. 2017;11:270.","journal-title":"Front Cell Neurosci"},{"key":"3900_CR101","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation. 2021;18:258.","journal-title":"J Neuroinflammation"},{"key":"3900_CR102","volume":"127","author":"J-B Belge","year":"2023","unstructured":"Belge J-B, Mulders P, Van Diermen L, Sienaert P, Sabbe B, Abbott CC, et al. Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level. Prog Neuropsychopharmacol Biol Psychiatry. 2023;127:110809.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3900_CR103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/YCT.0000000000000129","volume":"30","author":"F Bouckaert","year":"2014","unstructured":"Bouckaert F, Sienaert P, Obbels J, Dols A, Vandenbulcke M, Stek M, et al. ECT: its brain enabling effects: a review of electroconvulsive therapy-induced structural brain plasticity. J ECT. 2014;30:143\u201351.","journal-title":"J ECT"},{"key":"3900_CR104","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41380-024-02710-6","volume":"30","author":"F Long","year":"2025","unstructured":"Long F, Chen Y, Zhang Q, Li Q, Wang Y, Wang Y, et al. Predicting treatment outcomes in major depressive disorder using brain magnetic resonance imaging: a meta-analysis. Mol Psychiatry. 2025;30:825\u201337.","journal-title":"Mol Psychiatry"},{"key":"3900_CR105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/ajp.151.5.791","volume":"151","author":"DP Devanand","year":"1994","unstructured":"Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure?. Am J Psychiatry. 1994;151:957\u201370.","journal-title":"Am J Psychiatry"},{"key":"3900_CR106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/YCT.0b013e3181a95da8","volume":"26","author":"P Nordanskog","year":"2010","unstructured":"Nordanskog P, Dahlstrand U, Larsson MR, Larsson E-M, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT. 2010;26:62\u201367.","journal-title":"J ECT"},{"key":"3900_CR107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1192\/bjp.2017.11","volume":"212","author":"A Takamiya","year":"2018","unstructured":"Takamiya A, Chung JK, Liang K-C, Graff-Guerrero A, Mimura M, Kishimoto T. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br J Psychiatry. 2018;212:19\u201326.","journal-title":"Br J Psychiatry"},{"key":"3900_CR108","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/acps.12884","volume":"138","author":"K Gbyl","year":"2018","unstructured":"Gbyl K, Videbech P. Electroconvulsive therapy increases brain volume in major depression: a systematic review and meta-analysis. Acta Psychiatr Scand. 2018;138:180\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR109","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2018.05.017","volume":"84","author":"L Oltedal","year":"2018","unstructured":"Oltedal L, Narr KL, Abbott C, Anand A, Argyelan M, Bartsch H, et al. Volume of the human hippocampus and clinical response following electroconvulsive therapy. Biol Psychiatry. 2018;84:574\u201381.","journal-title":"Biol Psychiatry"},{"key":"3900_CR110","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41380-019-0392-6","volume":"25","author":"JO Nuninga","year":"2020","unstructured":"Nuninga JO, Mandl RCW, Boks MP, Bakker S, Somers M, Heringa SM, et al. Volume increase in the dentate gyrus after electroconvulsive therapy in depressed patients as measured with 7T. Mol Psychiatry. 2020;25:1559\u201368.","journal-title":"Mol Psychiatry"},{"key":"3900_CR111","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41386-019-0312-0","volume":"44","author":"A Takamiya","year":"2019","unstructured":"Takamiya A, Plitman E, Chung JK, Chakravarty M, Graff-Guerrero A, Mimura M, et al. Acute and long-term effects of electroconvulsive therapy on human dentate gyrus. Neuropsychopharmacology. 2019;44:1805\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"3900_CR112","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1192\/bjp.2018.224","volume":"214","author":"G Gryglewski","year":"2019","unstructured":"Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Kl\u00f6bl M, et al. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis. Br J Psychiatry. 2019;214:159\u201367.","journal-title":"Br J Psychiatry"},{"key":"3900_CR113","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110048","volume":"104","author":"K Gbyl","year":"2021","unstructured":"Gbyl K, Rostrup E, Raghava JM, Andersen C, Rosenberg R, Larsson HBW, et al. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110048.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3900_CR114","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/acps.13259","volume":"143","author":"K Gbyl","year":"2021","unstructured":"Gbyl K, St\u00f8ttrup MM, Mitta Raghava J, Xue Jie S, Videbech P. Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta Psychiatr Scand. 2021;143:238\u201352.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.stem.2018.03.015","volume":"22","author":"M Boldrini","year":"2018","unstructured":"Boldrini M, Fulmore CA, Tartt AN, Simeon LR, Pavlova I, Poposka V, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589\u2013.e5.","journal-title":"Cell Stem Cell"},{"key":"3900_CR116","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.cell.2013.05.002","volume":"153","author":"KL Spalding","year":"2013","unstructured":"Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153:1219\u201327.","journal-title":"Cell"},{"key":"3900_CR117","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0006-3223(00)00228-6","volume":"47","author":"TM Madsen","year":"2000","unstructured":"Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstr\u00f6m A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043\u20139.","journal-title":"Biol Psychiatry"},{"key":"3900_CR118","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0237-07.2007","volume":"27","author":"TD Perera","year":"2007","unstructured":"Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, et al. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci. 2007;27:4894\u2013901.","journal-title":"J Neurosci"},{"key":"3900_CR119","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.brs.2015.05.011","volume":"8","author":"RJ Schloesser","year":"2015","unstructured":"Schloesser RJ, Orvoen S, Jimenez DV, Hardy NF, Maynard KR, Sukumar M, et al. Antidepressant-like effects of electroconvulsive seizures require adult neurogenesis in a neuroendocrine model of depression. Brain Stimul. 2015;8:862\u20137.","journal-title":"Brain Stimul"},{"key":"3900_CR120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41386-023-01791-1","volume":"49","author":"Y Abe","year":"2024","unstructured":"Abe Y, Yokoyama K, Kato T, Yagishita S, Tanaka KF, Takamiya A. Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation. Neuropsychopharmacology. 2024;49:1236\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"3900_CR121","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02658-1","volume":"13","author":"D Loef","year":"2023","unstructured":"Loef D, Tendolkar I, van Eijndhoven PFP, Hoozemans JJM, Oudega ML, Rozemuller AJM, et al. Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients. Transl Psychiatry. 2023;13:355.","journal-title":"Transl Psychiatry"},{"key":"3900_CR122","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.brs.2024.04.020","volume":"17","author":"M Laroy","year":"2024","unstructured":"Laroy M, Vande Casteele T, Van Cauwenberge M, Koole M, Dupont P, Sunaert S, et al. Synaptic density changes following electroconvulsive therapy: A longitudinal pilot study with PET-MR 11C-UCB-J imaging in late-life depression. Brain Stimul. 2024;17:588\u201390.","journal-title":"Brain Stimul"},{"key":"3900_CR123","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41380-025-03016-x","volume":"30","author":"A Le Berre","year":"2025","unstructured":"Le Berre A, Attali D, Uszynski I, Debacker C, Lui M, Charron S, et al. Hippocampal microstructural changes following electroconvulsive therapy in severe depression. Mol Psychiatry. 2025;30:4343\u201352. https:\/\/doi.org\/10.1038\/s41380-025-03016-x.","journal-title":"Mol Psychiatry"},{"key":"3900_CR124","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.brs.2020.04.017","volume":"13","author":"JO Nuninga","year":"2020","unstructured":"Nuninga JO, Mandl RCW, Froeling M, Siero JCW, Somers M, Boks MP, et al. Vasogenic edema versus neuroplasticity as neural correlates of hippocampal volume increase following electroconvulsive therapy. Brain Stimul. 2020;13:1080\u20136.","journal-title":"Brain Stimul"},{"key":"3900_CR125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41386-024-01894-3","volume":"50","author":"NB Al-Sharif","year":"2024","unstructured":"Al-Sharif NB, Zavaliangos-Petropulu A, Narr KL. A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response. Neuropsychopharmacology. 2024;50:211\u201329.","journal-title":"Neuropsychopharmacology"},{"key":"3900_CR126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1176\/appi.ajp.161.3.576","volume":"161","author":"AJ Dwork","year":"2004","unstructured":"Dwork AJ, Arango V, Underwood M, Ilievski B, Rosoklija G, Sackeim HA, et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry. 2004;161:576\u20138.","journal-title":"Am J Psychiatry"},{"key":"3900_CR127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/YCT.0b013e31804bb99d","volume":"23","author":"J Scalia","year":"2007","unstructured":"Scalia J, Lisanby SH, Dwork AJ, Johnson JE, Bernhardt ER, Arango V, et al. Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression. J ECT. 2007;23:96\u201398.","journal-title":"J ECT"},{"key":"3900_CR128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/YCT.0000000000000062","volume":"30","author":"D Anderson","year":"2014","unstructured":"Anderson D, Wollmann R, Dinwiddie SH. Neuropathological evaluation of an 84-year-old man after 422 ECT treatments. J ECT. 2014;30:248\u201350.","journal-title":"J ECT"},{"key":"3900_CR129","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/YCT.0000000000000630","volume":"35","author":"A Takamiya","year":"2019","unstructured":"Takamiya A, Nuninga JO, Mandl RCW, Sommer IEC, Mimura M, Kishimoto T. Volume Increase of the Dentate Gyrus Induced by Electroconvulsive Therapy: Shedding Light on the Clinical Relevance of Plasticity in the Hippocampus. J ECT. 2019;35:e57\u2013e58.","journal-title":"J ECT"},{"key":"3900_CR130","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.124","volume":"4","author":"CC Abbott","year":"2014","unstructured":"Abbott CC, Jones T, Lemke NT, Gallegos P, McClintock SM, Mayer AR, et al. Hippocampal structural and functional changes associated with electroconvulsive therapy response. Transl Psychiatry. 2014;4:e483.","journal-title":"Transl Psychiatry"},{"key":"3900_CR131","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.brs.2021.06.011","volume":"14","author":"A Takamiya","year":"2021","unstructured":"Takamiya A, Bouckaert F, Laroy M, Blommaert J, Radwan A, Khatoun A, et al. Biophysical mechanisms of electroconvulsive therapy-induced volume expansion in the medial temporal lobe: A longitudinal in vivo human imaging study. Brain Stimul. 2021;14:1038\u201347.","journal-title":"Brain Stimul"},{"key":"3900_CR132","first-page":"300","volume":"4","author":"A Kubicki","year":"2019","unstructured":"Kubicki A, Leaver AM, Vasavada M, Njau S, Wade B, Joshi SH, et al. Variations in hippocampal white matter diffusivity differentiate response to electroconvulsive therapy in major depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:300\u20139.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3900_CR133","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1017\/S0033291720001518","volume":"51","author":"A Takamiya","year":"2021","unstructured":"Takamiya A, Kishimoto T, Hirano J, Nishikata S, Sawada K, Kurokawa S, et al. Neuronal network mechanisms associated with depressive symptom improvement following electroconvulsive therapy. Psychol Med. 2021;51:2856\u201363.","journal-title":"Psychol Med"},{"key":"3900_CR134","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S0033291718002684","volume":"49","author":"T Bai","year":"2019","unstructured":"Bai T, Wei Q, Xie W, Wang A, Wang J, Ji G-J, et al. Hippocampal-subregion functional alterations associated with antidepressant effects and cognitive impairments of electroconvulsive therapy. Psychol Med. 2019;49:1357\u201364.","journal-title":"Psychol Med"},{"key":"3900_CR135","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1038\/s41380-020-0666-z","volume":"26","author":"AM Leaver","year":"2021","unstructured":"Leaver AM, Vasavada M, Kubicki A, Wade B, Loureiro J, Hellemann G, et al. Hippocampal subregions and networks linked with antidepressant response to electroconvulsive therapy. Mol Psychiatry. 2021;26:4288\u201399.","journal-title":"Mol Psychiatry"},{"key":"3900_CR136","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01641-y","volume":"11","author":"M Argyelan","year":"2021","unstructured":"Argyelan M, Lencz T, Kang S, Ali S, Masi PJ, Moyett E, et al. ECT-induced cognitive side effects are associated with hippocampal enlargement. Transl Psychiatry. 2021;11:516.","journal-title":"Transl Psychiatry"},{"key":"3900_CR137","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature11850","volume":"493","author":"PW Frankland","year":"2013","unstructured":"Frankland PW, Josselyn SA. Neuroscience: memory and the single molecule. Nature. 2013;493:312\u20133.","journal-title":"Nature"},{"key":"3900_CR138","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biopsych.2019.07.010","volume":"87","author":"OT Ousdal","year":"2020","unstructured":"Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, et al. Brain changes induced by electroconvulsive therapy are broadly distributed. Biol Psychiatry. 2020;87:451\u201361.","journal-title":"Biol Psychiatry"},{"key":"3900_CR139","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110286","volume":"110","author":"A Takamiya","year":"2021","unstructured":"Takamiya A, Kishimoto T, Hirano J, Kikuchi T, Yamagata B, Mimura M. Association of electroconvulsive therapy-induced structural plasticity with clinical remission. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110286.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3900_CR140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41380-023-02318-2","volume":"29","author":"M Argyelan","year":"2024","unstructured":"Argyelan M, Deng Z-D, Ousdal OT, Oltedal L, Angulo B, Baradits M, et al. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. Mol Psychiatry. 2024;29:229\u201337.","journal-title":"Mol Psychiatry"},{"key":"3900_CR141","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49115","volume":"8","author":"M Argyelan","year":"2019","unstructured":"Argyelan M, Oltedal L, Deng Z-D, Wade B, Bikson M, Joanlanne A, et al. Electric field causes volumetric changes in the human brain. eLife. 2019;8:e49115.","journal-title":"eLife"},{"key":"3900_CR142","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41380-021-01380-y","volume":"27","author":"Z-D Deng","year":"2022","unstructured":"Deng Z-D, Argyelan M, Miller J, Quinn DK, Lloyd M, Jones TR, et al. Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes. Mol Psychiatry. 2022;27:1676\u201382.","journal-title":"Mol Psychiatry"},{"key":"3900_CR143","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.brs.2020.09.009","volume":"13","author":"R Francis-Taylor","year":"2020","unstructured":"Francis-Taylor R, Ophel G, Martin D, Loo C. The ictal EEG in ECT: A systematic review of the relationships between ictal features, ECT technique, seizure threshold and outcomes. Brain Stimul. 2020;13:1644\u201354.","journal-title":"Brain Stimul"},{"key":"3900_CR144","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.21","volume":"4","author":"H Lyden","year":"2014","unstructured":"Lyden H, Espinoza RT, Pirnia T, Clark K, Joshi SH, Leaver AM, et al. Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Transl Psychiatry. 2014;4:e380.","journal-title":"Transl Psychiatry"},{"key":"3900_CR145","volume":"12","author":"J-B Belge","year":"2022","unstructured":"Belge J-B, Mulders PCR, Van Diermen L, Schrijvers D, Sabbe B, Sienaert P, et al. White matter changes following electroconvulsive therapy for depression: a multicenter ComBat harmonization approach. Transl Psychiatry. 2022;12:517.","journal-title":"Transl Psychiatry"},{"key":"3900_CR146","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00406-015-0631-z","volume":"266","author":"T Nickl-Jockschat","year":"2016","unstructured":"Nickl-Jockschat T, Palomero Gallagher N, Kumar V, Hoffstaedter F, Br\u00fcgmann E, Habel U, et al. Are morphological changes necessary to mediate the therapeutic effects of electroconvulsive therapy?. Eur Arch Psychiatry Clin Neurosci. 2016;266:261\u20137.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3900_CR147","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S0033291719000758","volume":"50","author":"J Repple","year":"2020","unstructured":"Repple J, Meinert S, Bollettini I, Grotegerd D, Redlich R, Zaremba D, et al. Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging study. Psychol Med. 2020;50:849\u201356.","journal-title":"Psychol Med"},{"key":"3900_CR148","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ijnp\/pyz059","volume":"23","author":"G Gryglewski","year":"2020","unstructured":"Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, et al. Changes in white matter microstructure after electroconvulsive therapy for treatment-resistant depression. Int J Neuropsychopharmacol. 2020;23:20\u201325.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3900_CR149","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103404","volume":"38","author":"N Denier","year":"2023","unstructured":"Denier N, Walther S, Breit S, Mertse N, Federspiel A, Meyer A, et al. Electroconvulsive therapy induces remodeling of hippocampal co-activation with the default mode network in patients with depression. Neuroimage Clin. 2023;38:103404.","journal-title":"Neuroimage Clin"},{"key":"3900_CR150","first-page":"10","volume":"6","author":"E Tsolaki","year":"2021","unstructured":"Tsolaki E, Narr KL, Espinoza R, Wade B, Hellemann G, Kubicki A, et al. Subcallosal cingulate structural connectivity differs in responders and nonresponders to electroconvulsive therapy. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:10\u201319.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3900_CR151","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/hbm.22099","volume":"34","author":"B Jeurissen","year":"2013","unstructured":"Jeurissen B, Leemans A, Tournier J-D, Jones DK, Sijbers J. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum Brain Mapp. 2013;34:2747\u201366.","journal-title":"Hum Brain Mapp"},{"key":"3900_CR152","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuroimage.2018.04.051","volume":"182","author":"O Pasternak","year":"2018","unstructured":"Pasternak O, Kelly S, Sydnor VJ, Shenton ME. Advances in microstructural diffusion neuroimaging for psychiatric disorders. Neuroimage. 2018;182:259\u201382.","journal-title":"Neuroimage"},{"key":"3900_CR153","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2024.09.036","volume":"179","author":"J Yang","year":"2024","unstructured":"Yang J, Tong P, Dong L-P, Shi Y-H. A novel approach to investigate the mechanism of electroconvulsive therapy in the treatment of major depression disorder: Diffusion kurtosis imaging. J Psychiatr Res. 2024;179:372\u20138.","journal-title":"J Psychiatr Res"},{"key":"3900_CR154","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/appi.ajp.20250289","volume":"182","author":"AH Miller","year":"2025","unstructured":"Miller AH. Advancing an inflammatory subtype of major depression. Am J Psychiatry. 2025;182:516\u201324.","journal-title":"Am J Psychiatry"},{"key":"3900_CR155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106143","volume":"173","author":"M Laroy","year":"2025","unstructured":"Laroy M, Emsell L, Vandenbulcke M, Bouckaert F. Mapping electroconvulsive therapy induced neuroplasticity: Towards a multilevel understanding of the available clinical literature - A scoping review. Neurosci Biobehav Rev. 2025;173:106143.","journal-title":"Neurosci Biobehav Rev"},{"key":"3900_CR156","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbi.2016.03.025","volume":"56","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD, et al. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun. 2016;56:281\u20138.","journal-title":"Brain Behav Immun"},{"key":"3900_CR157","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2023.0728","volume":"80","author":"M Cano","year":"2023","unstructured":"Cano M, Camprodon JA. Understanding the mechanisms of action of electroconvulsive therapy: revisiting neuroinflammatory and neuroplasticity hypotheses. JAMA Psychiatry. 2023;80:643\u20134.","journal-title":"JAMA Psychiatry"},{"key":"3900_CR158","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/acps.13631","volume":"149","author":"S Ferrea","year":"2024","unstructured":"Ferrea S, Petrides G, Ehrt-Sch\u00e4fer Y, Angst J, Seifritz E, Olbrich S, et al. Outcomes of electroconvulsive therapy in patients with depressive symptoms with versus without comorbid personality disorders\/traits: A systematic review and meta-analysis. Acta Psychiatr Scand. 2024;149:18\u201332.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR159","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/YCT.0000000000000945","volume":"39","author":"M Finnegan","year":"2023","unstructured":"Finnegan M, Galligan T, Jelovac A, McLoughlin DM. Personality difficulties as a predictor of electroconvulsive therapy response in depression. J ECT. 2023;39:204\u20135.","journal-title":"J ECT"},{"key":"3900_CR160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/YCT.0000000000000900","volume":"39","author":"AP Nicolini","year":"2023","unstructured":"Nicolini AP, Sienaert P. Borderline personality disorder and outcome of electroconvulsive therapy in patients with depression: a systematic review. J ECT. 2023;39:74\u201380.","journal-title":"J ECT"},{"key":"3900_CR161","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.brs.2024.07.012","volume":"17","author":"S Thompson","year":"2024","unstructured":"Thompson S, Finnegan M, Galligan T, Jelovac A, McLoughlin DM. Childhood trauma and response to electroconvulsive therapy for depression: A pilot study. Brain Stimul. 2024;17:864\u201386.","journal-title":"Brain Stimul"},{"key":"3900_CR162","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/acps.13756","volume":"151","author":"A Jelovac","year":"2025","unstructured":"Jelovac A, Mohan C, Whooley E, Igoe A, McCaffrey C, McLoughlin DM. Childhood maltreatment and outcomes following electroconvulsive therapy in adults with depression. Acta Psychiatr Scand. 2025;151:46\u201355.","journal-title":"Acta Psychiatr Scand"},{"key":"3900_CR163","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jad.2019.02.057","volume":"250","author":"K Rootes-Murdy","year":"2019","unstructured":"Rootes-Murdy K, Carlucci M, Tibbs M, Wachtel LE, Sherman MF, Zandi PP, et al. Non-suicidal self-injury and electroconvulsive therapy: outcomes in adolescent and young adult populations. J Affect Disord. 2019;250:94\u201398.","journal-title":"J Affect Disord"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03900-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:02:35Z","timestamp":1771592555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03900-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3900"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03900-2","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing financial interests in relation to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}